Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1967 May;30(1):99–107. doi: 10.1111/j.1476-5381.1967.tb02116.x

The effect of infusing noradrenaline or of stimulating the sympathetic nerves on the blood pressure response to indirect sympathomimetics.

J S Gillespie, T C Muir
PMCID: PMC1557244  PMID: 6039976

Full text

PDF
107

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BURN J. H., RAND M. J. The action of sympathomimetic amines in animals treated with reserpine. J Physiol. 1958 Dec 4;144(2):314–336. doi: 10.1113/jphysiol.1958.sp006104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bülbring E., Burn J. H. An action of adrenaline on transmission in sympathetic ganglia, which may play a part in shock. J Physiol. 1942 Nov 30;101(3):289–303. doi: 10.1113/jphysiol.1942.sp003983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DE SCHAEPDRYVER A. F., BOGAERT M., DELAUNOIS A. L., BERNARD P. Peripheral noradrenergic reactivity. Arch Int Pharmacodyn Ther. 1963 Mar 1;142:243–259. [PubMed] [Google Scholar]
  4. DUNER H., VON EULER U. S. Secondary fall in blood pressure following noradrenaline infusion in the cat. Acta Physiol Scand. 1957 Mar 7;38(3-4):355–363. doi: 10.1111/j.1748-1716.1957.tb01397.x. [DOI] [PubMed] [Google Scholar]
  5. Gillespie J. S., Hamilton D. N. Binding of noradrenaline to smooth muscle cells in the spleen. Nature. 1966 Oct 29;212(5061):524–525. doi: 10.1038/212524a0. [DOI] [PubMed] [Google Scholar]
  6. Gillespie J. S., Muir T. C. A method of stimulating the complete sympathetic outflow from the spinal cord to blood vessels in the pithed rat. Br J Pharmacol Chemother. 1967 May;30(1):78–87. doi: 10.1111/j.1476-5381.1967.tb02114.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gillespie J. S., Muir T. C. The origin of the decline in the vasopressor response to infused noradrenaline in the pithed rat. Br J Pharmacol Chemother. 1967 May;30(1):88–98. doi: 10.1111/j.1476-5381.1967.tb02115.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Muscholl E. Modification of sympathetic function. Indirectly acting sympathomimetic amines. Pharmacol Rev. 1966 Mar;18(1):551–559. [PubMed] [Google Scholar]
  9. NASMYTH P. A. An investigation of the action of tyramine and its interrelationship with the effects of other sympathomimetic amines. Br J Pharmacol Chemother. 1962 Feb;18:65–75. doi: 10.1111/j.1476-5381.1962.tb01151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. RAAB W., GIGEE W. Specific avidity of the heart muscle to absorb and store epinephrine and norepinephrine. Circ Res. 1955 Nov;3(6):553–558. doi: 10.1161/01.res.3.6.553. [DOI] [PubMed] [Google Scholar]
  11. Trendelenburg U. Mechanisms of supersensitivity and subsensitivity to sympathomimetic amines. Pharmacol Rev. 1966 Mar;18(1):629–640. [PubMed] [Google Scholar]
  12. WEINER N., DRASKOCZY P. R., BURACK W. R. The ability of tyramine to liberate catecholamines in vivo. J Pharmacol Exp Ther. 1962 Jul;137:47–55. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES